1. Second generation androgen receptor antagonist, TQB3720 abrogates prostate cancer growth via AR/GPX4 axis activated ferroptosis
   Zhongqing Zhang et al, 2023, Frontiers in Pharmacology CrossRef
2. The Hippo effector YAP1/TEAD1 regulates EPHA3 expression to control cell contact and motility
   Marwah M. Al-Mathkour et al, 2022, Scientific Reports CrossRef
3. Critical role of EphA3 in cancer and current state of EphA3 drug therapeutics
   Max London et al, 2020, Molecular Biology Reports CrossRef
4. The androgen receptor inhibits transcription of GPER1 by preventing Sp1 and Sp3 from binding to the promoters in prostate cancer cells
   Austin McDermott et al, 2022, Oncotarget CrossRef